Fate Therapeutics Inc (FATE)
2.065
-0.16
(-6.98%)
USD |
NASDAQ |
Nov 21, 16:00
2.07
0.00 (0.00%)
After-Hours: 20:00
Fate Therapeutics Price to Book Value: 0.6491 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 0.6978 |
| November 19, 2024 | 0.6853 |
| November 18, 2024 | 0.7136 |
| November 15, 2024 | 0.635 |
| November 14, 2024 | 0.6538 |
| November 13, 2024 | 0.6821 |
| November 12, 2024 | 0.7481 |
| November 11, 2024 | 0.8047 |
| November 08, 2024 | 0.7607 |
| November 07, 2024 | 0.8016 |
| November 06, 2024 | 0.877 |
| November 05, 2024 | 0.8424 |
| November 04, 2024 | 0.8675 |
| November 01, 2024 | 0.7638 |
| October 31, 2024 | 0.7449 |
| October 30, 2024 | 0.7827 |
| October 29, 2024 | 0.8549 |
| October 28, 2024 | 0.9021 |
| October 25, 2024 | 0.8329 |
| October 24, 2024 | 0.8832 |
| October 23, 2024 | 0.9524 |
| October 22, 2024 | 1.003 |
| October 21, 2024 | 0.9901 |
| October 18, 2024 | 1.015 |
| October 17, 2024 | 1.012 |
| Date | Value |
|---|---|
| October 16, 2024 | 1.009 |
| October 15, 2024 | 0.9587 |
| October 14, 2024 | 0.9587 |
| October 11, 2024 | 0.9712 |
| October 10, 2024 | 0.9241 |
| October 09, 2024 | 0.9461 |
| October 08, 2024 | 0.965 |
| October 07, 2024 | 0.9587 |
| October 04, 2024 | 1.012 |
| October 03, 2024 | 0.9807 |
| October 02, 2024 | 1.009 |
| October 01, 2024 | 1.053 |
| September 30, 2024 | 1.100 |
| September 27, 2024 | 1.024 |
| September 26, 2024 | 1.004 |
| September 25, 2024 | 0.9897 |
| September 24, 2024 | 0.9897 |
| September 23, 2024 | 1.044 |
| September 20, 2024 | 1.110 |
| September 19, 2024 | 1.147 |
| September 18, 2024 | 1.113 |
| September 17, 2024 | 1.147 |
| September 16, 2024 | 1.136 |
| September 13, 2024 | 1.153 |
| September 12, 2024 | 1.073 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4039
Minimum
Oct 27 2023
28.35
Maximum
Jan 14 2021
5.786
Average
4.781
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.291 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.263 |
| Theriva Biologics Inc | 0.1446 |
| Oragenics Inc | 2.223 |
Price to Book Value Related Metrics
| PS Ratio | 16.70 |
| Price | 2.065 |
| Earnings Yield | -79.90% |
| Market Cap | 235.19M |